1-(4-(Aminomethyl)phenyl)-N-methylmethanamine, 95%, 500mg

(S)-3-(2-Bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 100mg

Carbidopa Monohydrate>98.0%(HPLC)(T)100mg

(1,1-Dimethylethyl)dimethyl[[(3β,5E,7E)-9,10-secocholesta-5,7,10(19)-trien-3-yl]oxy]silane, 98%, 100mg

GC capillary column ROTI®Cap-5, 25 m, 0.53 mm, 0.50 µm, 1 Piece(s)

3,3-dimethyl-1-(2-methylpiperazin-1-yl)butan-1-one, 95.0%, 1g

3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline, 98.0%, 1g

tert-Butyl (S)-3-(2-ethoxy-2-oxoethyl)piperazine-1-carboxylate, 98%, 250mg

ETHYL 2-FORMYL-1H-PYRROLE-3-CARBOXYLATE, 95%, 100mg

[(5-methoxy-1H-benzimidazol-2-yl)methyl]amine dihydrochloride, 95.0%, 10g

3-Bromo-2-methoxy-4-methylpyridine, 95.0%, 5g

Gb5-beta-pNP>95.0%(HPLC)5mg

2-[(4-Fluoro-benzyl)-methyl-amino]-ethanol, 95.0%, 500mg